Stay updated with breaking news from Davida Ricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eli Lilly has announced that it is reducing the list price of its insulin by 70% and capping out-of-pocket costs at $35 a month as part of its Insulin Value Program. Effective immediately, Lilly will automatically cap out-of-pocket costs at $35 at participating retail pharmacies for people with commercial insurance using Lilly insulin. Lilly is cutting the list price of its
As of May 1, non-branded insulins will cost $25 a vial, and Lilly says it will immediately cap out-of-pocket costs at $35 per month.
Plus, a concerning rise in colorectal cancer among young people, what Chicago voters signaled to the rest of the country, and more.
This particular pharmaceutical giant is super proud of itself and wants a cookie.
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its...